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Abstract
Eccrine porocarcinoma is a rare malignancy of the eccrine sweat gland. It is usually found frequently on the lower
extremities, and it affects both sexes equally usually in the sixth to seventh decade. In our case, we present a 42-
year-old male patient with a recurring exophytic tumor on the right lower extremity without local extension. The
initial tumor was biopsied, excised and diagnosed as an eccrine poroma. The tumor then recurred 6 years later,
was re-excised, reconstructed with a soleus muscle flap and diagnosed as an eccrine porocarcinoma.
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Background
Eccrine porocarcinoma (EPC), a rare malignant sweat
gland tumor, representing only 0.005% of epithelial cuta-
neous neoplasms. The first reported case, in 1963, was
attributed to Pinkus and Mehregan [1], coined as “epider-
motropic eccrine carcinoma”, and since then, presentation
have been limited due to the rarity of this tumor. It was
only a few years later, the term “eccrine porocarcinoma”
was introduced by Mishma and Morioka in 1969 [2].
These lesions are most commonly found on the lower
extremities, followed by the head, scalp, upper extremities,
trunk and abdomen [1,3-11]. The tumor can arise from
the intraepithelial portion of the eccrine sweat gland, the
acrosyringium, being a primary tumor or, even more com-
mon, a malignant transformation of an eccrine poroma
(EP). In this case, we present a 42-year-old patient with a
right lower extremity mass that was previously diagnosed
with a benign poroma later, over 6 years, found to have
had malignant transformation.
Case Report
A 42-year-old male presented with an exophytic mass on
the right lower extremity that had developed over the last
6 years. The patient denied any type of trauma to the area
or insect bites. The mass had been previously excised and
pathology showed a benign poroma. The laboratory work-
up for this patient was within normal limits.
On physical exam, there were no lymphadenopathy in
the inguinal, axillary or clavicular areas were noted. The
tumor itself measured 3.0 × 2.0 cm with a width of 0.6 cm
(Figure 1). Pink exophytic, fungating outgrowths are a sig-
nature to this tumor. In combination with the patient’s
previous history of benign poroma, the treatment of
choice was a wide local excision of the mass with 2.5 cm
margins - both circumferentially and deep to the level of
the periosteum. A soleus muscle flap was then raised and
used to reconstruct the defect. The muscle was then cov-
ered with a split thickness skin graft.
The macroscopic examination of the specimen showed
an exophytic mass measuring 3 cm in diameter. Micro-
scopically, the specimen displayed malignant eosinophi-
lic lobular masses with eosinophilic polyhedral fusiform
cells that contained variable cytoplasm, hyperchromatic
nuclei, distinct nucleoli and indistinct cell boundaries
(Figure 2). There was obvious atypia and frequent mito-
tic figures, epidermotropism, variable squamous differ-
entiation and cell changes with pigmentation in a
horizontal nodular pattern. Both carcinoma in situ and
invasive components were noted (Figure 3).
The final pathology report stated the specimen was a
porocarcinoma in situ with clear surgical margins. Dur-
ing the 6 month and 1 year post-op follow up, the
wound had healed without any complications or recur-
rence (Figure 4). The physical exam remains unchanged
with no palpable regional lymph nodes.
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Eccrine porocarcinoma (EPC) is more common in
elderly patients and most cases occur in the sixth to
seventh decade of life. In our case, we presented a male
in his early 40 s and with time, has become malignant
from a previous benign poroma. Men and women are
usually equally affected, and prevalence varies in both
sex in diverse studies [12-14]. Approximately 50% of
EPC appear first in the lower limbs; in that, more than
40% occur below the knees [15]. Less than 5% involve
the scalp [16]. Other affected sites are face, ear, eyelids,
abdomen, vulva, penis and pubis.
Theorectically, eccrine porocarcinoma progresses from
benign to malignant. This is supported clinically by long
histories, mean 8.5 years and recent onset of rapid
growth in longstanding cases. Only a period of 6 years
duration was noted in our case. Histological reports of
dysplasia and malignant change in benign variants,
including eccrine poroma and hidroacanthoma simplex
support this theory [17].
The pathogenesis and roles of possible pre-invasive
precursors of this lesion is still unknown [18]. It seems
that the upper portion of the dermal eccrine duct could
have a role in the oncogenesis. More recently, the p53
gene involved in tumor suppressing, could be involved
in EPC carcinogenesis [19]. Throughout the literature
search, there is not a definite time line in which a por-
oma advances and becomes a porocarcinoma.
Treatment of choice for EPC is total surgical excision
with broad tumor margins and regional lymph node dis-
ection if involved. There is still insufficient literature
Figure 1 Preoperative image of the pink exophytic outgrowth
- 2.0 × 3.0 cm.
Figure 2 The tumor cells are in-situ and invasive. Malignant
eosinophilic lobular masses or islands are seen with eosinophilic
cells that are polyhedral and fusiform that have variable cytoplasm,
hyperchromatic nuclei and indistinct cell boundaries.
Figure 3 High power view show invasive carcinoma cells. There
is obvious cell atypia with many mitotic figures seen. The squamous
cells have variable differentiation accompanied with changes in
pigmentation that are aligned in a horizontal nodular pattern. Both
carcinoma in situ and invasive component noted.
Figure 4 Postoperative image of the excised area with a soleus
muscle flap reconstruction.
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rately assess indication and tumor recurrence [18]. Che-
motherapy with methotrexate, cisplatin, adriamycin and
bleomycin or isotretinoin and interferon alpha have
been used with partial or little response. Radiation ther-
apy and chemotherapy seem to be ineffective to control
tumor recurrence or metastasis [16]. In our case, post-
op chemotherapy or radiation was not given to the
patient. There is no effective definitive treatment avail-
able for EPC at the moment but surgical excision is still
the treatment choice.
It is important to have this diagnosis as a differential
for cutaneous lesions due to the malignant nature of the
tumor if left unattended. EPC must be considered in the
differential diagnosis of patients older than fifty years
with long standing tumors in the limbs and head -
including basal cell carcinoma, Paget’s disease, mela-
noma and metastatic cancer. EPC has been documented
t oo c c u re v e ni nt h en a i lf o ld of the toe mimicking an
ingrown toe nail. Biopsy is indicated and, even with a
previous diagnosis of EP, one must be attentive to risk
of malignancy in the future or if it is a recurrence [20].
E P Ci sar a r em a l i g n a n c yo ft h ee c c r i n es w e a tg l a n d s
but yet curable if accurately diagnosed and properly
treated. Close follow-up to detect local recurrence and
lymph node metastasis is recommended since further
surgical intervention may be curative.
Conclusion
Eccrine porocarcinoma (EPC), a rare malignant sweat
gland tumor, representing only 0.005% of epithelial cuta-
neous neoplasms. Being only 0.005% of all cutaneous neo-
plasms makes this diagnosis intricate, but not impractical
if more literature is provided of this rare pathology. The
treatment is a multidisciplinary effort that consists of a
pathologist and surgeon. And if treated in the early stage,
surgery can be curative. EPC is a rare malignancy of the
eccrine sweat glands but yet curable if accurately diag-
nosed and properly treated. Due to the limited amount of
literature and cases documented, it is important to have a
basic knowledge of this disease process as a differential
diagnosis when dealing with cutaneous lesions.
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